Clinical Trial: Pilot Study on the Efficacy and Safety of FIBRORESTIL(R) as an Adjuvant Intralesional Treatment in Patients With Peyronie's Disease Receiving Standard Therapy

U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07341529) titled 'Pilot Study on the Efficacy and Safety of FIBRORESTIL(R) as an Adjuvant Intralesional Treatment in Patients With Peyronie's Disease Receiving Standard Therapy' on Jan. 06.

Brief Summary: Peyronie's disease is a connective tissue disorder of the penis characterized by the formation of fibrous plaques in the tunica albuginea, leading to penile curvature, possible erectile dysfunction, and significant physical and psychological distress. While surgical correction is effective, it is invasive and associated with potential complications. Conservative treatments such as penile traction therapy and oral phosphodiesterase-5 inhibitors are c...